Cholinergic modulation of growth
hormone, prolactin and thyroid stimulating
hormone responses to thyrotropin-releasing
hormone in normal aging.
Recenti Prog Med. 1995 Sep;86(9):341-4.
PMID: 7569294 [PubMed - indexed for MEDLINE]
Differing responses of cortisol
to oCRF during endonasal and oral treatment with
DDAVP.
Eur J Clin Invest. 1994 Jul;24(7):459-62.
PMID: 7957502 [PubMed - indexed for MEDLINE]
A cross-over study with the two
novel dopaminergic drugs cabergoline and
quinagolide in hyperprolactinemic patients.
J Endocrinol Invest. 1994 Jan;17(1):51-7.
PMID: 7911813 [PubMed - indexed for MEDLINE]
[Behavior of the
pituitary-thyroid axis in acromegalic subjects
during prolonged intermittent and pulsatile
treatment with octreotide]
Recenti Prog Med. 1994 Jan;85(1):7-12.
Italian.
PMID: 8184183 [PubMed - indexed for MEDLINE]
Delta sleep-inducing peptide
administration does not influence growth hormone
and prolactin secretion in normal women.
Psychoneuroendocrinology.
1993;18(1):79-84.
PMID: 8475226 [PubMed - indexed for MEDLINE]
[Treatment of central diabetes
insipidus using oral DDAVP. Comparison with
intranasal treatment] Minerva
Endocrinol. 1991 Jul-Sep;16(3):141-5.
Italian.
PMID: 1806811 [PubMed - indexed for MEDLINE]
LHRH-induced gonadotropin release before and
after short-term therapy with cabergoline in
hyperprolactinaemic patients. Minerva
Endocrinol. 1991 Jan-Mar;16(1):11-6.
PMID: 1944011 [PubMed - indexed for MEDLINE]